Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group

Authors :: L. Alessio
C. D'Ambrosio
L. Fondacaro
R. Villani
P. Guarascio
Luca Fontanella
Paola Begini
Adriano M. Pellicelli
A. Barlattani
Antonio Ascione
Giorgio Barbarini
E. D’amico
Massimo Marignani
Alessandra Moretti
Antonio Izzi
Giuseppe Maria Ettorre
G. Scifo
Pascal Vignally
V. Pace Palitti
Vincenzo Messina
Pierluigi Tarquini
L. Miglioresi
O. Armignacco
G. Cerasari
Source :: Digestive and Liver Disease. 48:e42
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: medicine.medical_specialty
Regimen
Hepatology
Sofosbuvir
business.industry
Internal medicine
Gastroenterology
medicine
business
Direct acting
medicine.drug
Surgery

Tools